COPD 2021

Allen Fred Fielding, Speaker at COPD Congress
Keynote Presentation
Allen Fred Fielding, Temple University, United States

During the last five years a new epidemic has been increasing without the needed attention that is needed to control it. Teen Vaping has increased markedly from 2017 to tripling by 2020 and has been on the increase since. Interesting is the fact that in the middle of the year of [....] » Read More

Ahmed Al Jumaily, Speaker at Pulmonology Conference
Keynote Presentation
Ahmed Al Jumaily, Auckland University of Technology, New Zealand

Lung therapies vary between pharmaceutical and physical treatments depending on the nature of the diseases. The latter has gained enormous applications in particular in managing airway constrictions such as during an asthmatic attack.  Pressure oscillation (PO) is a form of [....] » Read More

Jordan B Minov, Speaker at Pulmonology Congress 2022
Keynote Presentation
Jordan B Minov, Institute for Occupational Health, North Macedonia

Chronic obstructive pulmonary disease (COPD) is a major cause of disability and one of the leading causes of death throughout the world. Although the cigarette smoking is the major and the best studied causative factor of COPD, there is consistent evidence that a substantial prop [....] » Read More

Gilbert GLADY, Speaker at COPD Conferences
Keynote Presentation
Gilbert GLADY, European Bio Immune(G)Ene Medicine Association (EBMA), France

Asthma is a complex, heterogeneous and chronic airway inflammatory disease with different clinical phenotypes caused by diverse triggers and pathophysiological mechanisms. Asthma heritability has been established in many genetic studies, but it is becoming increasingly clear that [....] » Read More

Sho Shibata, Speaker at  Pulmonology Conferences
Oral Presentation
Sho Shibata, Tokyo Medical and Dental University, Japan

Chronic obstructive pulmonary disease (COPD) is estimated to affect 174.5 million persons in the global population and is the fourth leading cause of death in the world. It has been generally considered as a non-Th2-type lung disorder, characterized by progressive airflow limitat [....] » Read More

Po Ching Huang, Speaker at COPD Conference
Oral Presentation
Po Ching Huang, National Cheng Kung University, Taiwan

Exercise component in pulmonary rehabilitation benefits the Chronic Obstructive Pulmonary Disease (COPD) patients by improving the exercise capacity and health-related quality of life (HRQoL). However, patients with COPD were reported for their low motivation to participate in pu [....] » Read More

Hamid Mcheick, Speaker at COPD Congress
Oral Presentation
Hamid Mcheick, University of Quebec at Chicoutimi, Canada

Today, health system is reshaping the research in the medical domain due to its potential to concurrently overcome the challenges encountered in the traditional healthcare systems. Prediction of exacerbation of Chronic Obstructive Pulmonary Disease (COPD) is considered one of the [....] » Read More

Nazila Bahmaie, Speaker at COPD Conferences
Oral Presentation
Nazila Bahmaie, Near East University (NEU), Cyprus

From December 2019, a burgeoning rate of population have been involved in a highly contagious type of severe acute respiratory viral disorder identified with a new type of coronavirus in the Huanan seafood wholesale market of Wuhan, Hubei province, China. Due to the high rate of [....] » Read More

Pooja M R, Speaker at COPD Congress
Oral Presentation
Pooja M R, Vidyavardhaka College of Engineering, India

Intelligence has been an integral component of every aspect in all most all arenas of life. In the healthcare industry, the degree to which it has been impacted is comparatively low and the progress is in smaller steps when compared to those made in other fields. This can be attr [....] » Read More

Dipankar Bhattacharyya, Speaker at Pulmonology Conference
Oral Presentation
Dipankar Bhattacharyya, Chichuria Institute of Medical Science & Research, India

It has been hypothesised that antiallergic medications (AAMs) like montelukast and levocetirizine both the two bitter chloro compounds could be repurposed either alone or combinedly as an antiviral against SARS-CoV-2, like chloroquine/hydroxychloroquine (CQ/HCQ), anorher two bitt [....] » Read More

Rekha Khandia, Speaker at Pulmonology Congress
Oral Presentation
Rekha Khandia, Barkatullah University, India

At present, almost all countries are suffering with the deadly consequences of the SARS CoV-2 virus. Though ~80% among affected patients get recovered from this disease but patients suffering from comorbidities especially heart and lung diseases like, COPD (Chronic Obstructive Pu [....] » Read More

Hassan Motamed, Speaker at Pulmonology Conference
Oral Presentation
Hassan Motamed, Ahvaz Jundishapur University of Medical Sciences, Iran (Islamic Republic of)

Background: As a chronic disease of respiratory system, asthma affects millions of people. Because of its suboptimal control, it remains as a burden for health systems. Immune-suppressive agents are the most prescribed medications in asthma patients. Tacrolimus is an immune suppr [....] » Read More

Mohammad Rabbani Khorasgani, Speaker at COPD Conferences
Oral Presentation
Mohammad Rabbani Khorasgani, University of Isfahan, Iran (Islamic Republic of)

“Lifestyle” is a way or style of people living in a special time and place. Lifestyle includes behaviours and functions of individuals which are formed in a specific geographical, economic, political, cultural and religious context and influenced by them. The human li [....] » Read More

Elham Harati, Speaker at Pulmonology Conference
Oral Presentation
Elham Harati, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Asthma is a chronic inflammatory disease of the lungs driven by T cell activation. Viola tricolor L. as a traditional medical herb could suppress activated T lymphocytes and has been used empirically for asthma remedy. In the present study, we investigated the anti-inflammatory e [....] » Read More

Seyyed Shamsadin Athari, Speaker at  Pulmonology Congress
Oral Presentation
Seyyed Shamsadin Athari, Zanjan University of Medical Sciences, Iran (Islamic Republic of)

The pandemic of coronavirus disease 2019 has inflicted millions of people in the world and caused severe complications in immunocompromised individuals. Some evidences suggest that severe COVID-19 complications are associated with the cytokine storm syndrome, contributing to the [....] » Read More

Nightingale Syabbalo, Speaker at Pulmonology Conference
Oral Presentation
Nightingale Syabbalo, Nabanji Medical Centre, Zambia

Chronic obstructive pulmonary disease (COPD) is currently considered the third leading cause of death in the world, and its prevalence, especially the milder form, is estimated to be about 25% of adults above 40 years. The main cause of COPD is chronic inhalation of cigarette smo [....] » Read More

Nalan Metin Aksu, Speaker at  COPD Conference
Oral Presentation
Nalan Metin Aksu, Hacettepe University, Turkey

COPD exacerbations are so common in Emergency Department (ED).  The vast majority of them are treated in ED because of lack of the ICU and ward beds and they are discharged from ED. So the evidence based management of COPD exacerbation is so important. In this presentation t [....] » Read More

Lukasz Koltowski, Speaker at  Pulmonology Congress
Oral Presentation
Lukasz Koltowski, Medical University of Warsaw, Poland

Remote spirometry is a novel form of supervised lung function testing of the patients in their homes. It consists of the patient performing a spirometry examination at home, using a mobile spirometer, under the supervision of a specialist who communicates online with the patient [....] » Read More

Simon Walsh, Speaker at COPD Conference
Poster Presentation
Simon Walsh, Health Economist, Ireland

Remote spirometry is a novel form of supervised lung function testing of the patients in their homes. It consists of the patient performing a spirometry examination at home, using a mobile spirometer, under the supervision of a specialist who communicates online with the patient [....] » Read More

Shikhar Tripathi, Speaker at COPD Congress
Poster Presentation
Shikhar Tripathi, Anna Medical College & Sir Ganga Ram Hospital, India

COVID-19 has led on to a global healthcare crisis, similar to none in the recent past. Special emphasis must be laid on the impact of the infection on patients with COPD and Asthma, considering the vulnerability seen in these groups toward previous coronavirus diseases. SARS-CoV- [....] » Read More

Arben Redjepi, Speaker at COPD Congress
Poster Presentation
Arben Redjepi, Cyril and Methodius University in Skopje, North Macedonia

Introduction: SCLC (Small cell lung carcinoma) is the most common cancer associated with paraneoplastic syndromes. In many cases of suspected ectopic secretion of ACTH (adrenocorticotropic hormone), it is difficult to confirm the diagnosis histologically or cytochemically, especi [....] » Read More

Elham Harati, Speaker at Pulmonology Conference
Poster Presentation
Elham Harati, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Background: Since anxiety may aggravate asthma outcomes and current anti-anxiety drugs may cause respiratory depression, the development of new anxiolytic therapies for asthmatic patients is critically needed. Viola tricolor L. has been used empirically for asthma remedy, but its [....] » Read More

Hassan Motamed, Speaker at Pulmonology Conference
Poster Presentation
Hassan Motamed, Ahvaz Jundishapur University of Medical Sciences, Iran (Islamic Republic of)

Asthma is an important chronic disease which imposes a huge financial pressure on medical health services. Acute attacks and referral to Emergency Department is a challenge. Many Environmental Factors influences asthma in addition to its hereditary basis. Asthma is the culprit of [....] » Read More

Lyudmyla Kuyun, Speaker at  Pulmonology Conference
Poster Presentation
Lyudmyla Kuyun, Bogomolets National Medical University, Ukraine

The cigarette smoke is the main reason for developing COPD, since this external irritant activates receptor cells of the innate immunity and this in turn leads to synthesis and release of proinflammatory cytokines, such as TNF-α, IL-1, and IL-6. Regulatory T-lymphocytes par [....] » Read More

Scientific Programs coming soon..

Watsapp